RIOK CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RIOK Gen Silencer sind erhältlich als RIOK CRISPR/Cas9 Knockout Plasmide und RIOK Double Nickase Plasmide. RIOK CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RIOK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RIOK1 CRISPR/Cas9 KO Plasmid (h) | sc-406395 | h | Gene Knockout | GFP | 0 | ||
RIOK1 HDR Plasmid (h) | sc-406395-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RIOK1 Double Nickase Plasmid (h) | sc-406395-NIC | h | Gene Knockout | Puromycin | 0 | ||
RIOK1 Double Nickase Plasmid (h2) | sc-406395-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RIOK1 CRISPR/Cas9 KO Plasmid (m) | sc-427928 | m | Gene Knockout | GFP | 0 | ||
RIOK1 HDR Plasmid (m) | sc-427928-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RIOK1 Double Nickase Plasmid (m) | sc-427928-NIC | m | Gene Knockout | Puromycin | 0 | ||
RIOK1 Double Nickase Plasmid (m2) | sc-427928-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RIOK2 CRISPR/Cas9 KO Plasmid (h) | sc-405172 | h | Gene Knockout | GFP | 0 | ||
RIOK2 HDR Plasmid (h) | sc-405172-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RIOK2 Double Nickase Plasmid (h) | sc-405172-NIC | h | Gene Knockout | Puromycin | 0 | ||
RIOK2 Double Nickase Plasmid (h2) | sc-405172-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RIOK2 CRISPR/Cas9 KO Plasmid (m) | sc-426346 | m | Gene Knockout | GFP | 0 | ||
RIOK2 HDR Plasmid (m) | sc-426346-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RIOK2 Double Nickase Plasmid (m) | sc-426346-NIC | m | Gene Knockout | Puromycin | 0 | ||
RIOK2 Double Nickase Plasmid (m2) | sc-426346-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RIOK CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RIOK1 CRISPR Activation Plasmid (h) | sc-406395-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 CRISPR Activation Plasmid (h2) | sc-406395-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 Lentiviral Activation Particles (h) | sc-406395-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 Lentiviral Activation Particles (h2) | sc-406395-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 CRISPR Activation Plasmid (m) | sc-427928-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 CRISPR Activation Plasmid (m2) | sc-427928-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 Lentiviral Activation Particles (m) | sc-427928-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK1 Lentiviral Activation Particles (m2) | sc-427928-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 CRISPR Activation Plasmid (h) | sc-405172-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 CRISPR Activation Plasmid (h2) | sc-405172-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 Lentiviral Activation Particles (h) | sc-405172-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 Lentiviral Activation Particles (h2) | sc-405172-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 CRISPR Activation Plasmid (m) | sc-426346-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 CRISPR Activation Plasmid (m2) | sc-426346-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 Lentiviral Activation Particles (m) | sc-426346-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIOK2 Lentiviral Activation Particles (m2) | sc-426346-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |